Ozone therapy, at Fbf-Gemelli island kicks off major clinical research project

[vc_row][vc_column][vc_column_text]

Ozone therapy, at Fbf-Gemelli island kicks off major clinical research project

 

Rome, May 12 – An important clinical research and training project on Oxygen Ozone Therapy has started in Rome at the Fatebenefratelli Isola Tiberina-Gemelli Isola Hospital.The initiative involves scientific research, in-house training and delivery of therapeutic protocols in order to consolidate the effectiveness of Oxygen Ozone Therapy, with a particular focus on the prevention and treatment of neurodegenerative and aging-related diseases.

The inauguration of the project was held in recent days at the Fatebenefratelli Isola Tiberina-Gemelli Isola Hospital in Rome in the presence of distinguished personalities from the medical-scientific field and donor Lina Putortì, in memory of her husband Pippo Conti.

Ozone therapy is a therapy that exploits the abilities of oxygen (O2) and ozone (O3) on the human body at the metabolic, immune, vascular and regenerative levels.

In fact, through the use of different techniques, it allows significant therapeutic results to be obtained on numerous pathologies. thanks to pain-relieving, anti-inflammatory, antimicrobial, immunomodulating, revascularizing and revitalizing tissue action.Promoter of this project is Antonio Carlo Galoforo, who for more than 30 years has been dealing with the potential of the application of ozone in medicine and the environment, both in clinical practice and in scientific research, in national and international settings. Dr. Galoforo also serves as a Member of the Board of Directors of Sioot-Scientific Society of Ozone Ozone Therapy, as well as a lecturer of the Level II University Master’s Program in Ozone Ozone Therapy at the University of Pavia and Unicamillus in Rome. Within the section, projects already funded by the Ministry of Health, aimed at the effectiveness of Oxygen Ozone Therapy for the treatment of major neurodegenerative/neuropsychiatric diseases and aging-related frailty, will continue to be developed.

Research projects concluded in 2022 by Galoforo and researchers Catia Scassellati and Cristian Bonvicini at the Istituto Centro San Giovanni di Dio Fatebenefratelli (Irccs) in Brescia. Another key player in the project is ‘High Quality Italy,’ as promoter and partner for the strategic-relational and economic-legal aspects, carried out by lawyer Giuliana D’Antuono, who also handled the donation of the ‘Medical 95 Computerized Photometric System’ medical equipment. Other notable supporters include the ‘Prevention, Health and Welfare’ Commission of the European Academy for Economic and Cultural Relations (Aerec), represented by President Ernesto Carpintieri, for the support received at the institutional level as well.

(Red)

Content Original Link:
http://direnl.dire.it/odm/anno/2023/maggio/12/?news=N07

[/vc_column_text][vc_btn title=”Vedi l’articolo su OMCeO Roma” color=”turquoise” link=”url:https%3A%2F%2Fwww1.ordinemediciroma.it%2Fnewsletter-dire%2F33146-ozono-terapia-al-fbf-gemelli-isola-al-via-importante-progetto-ricerca-clinica.html”][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_single_image image=”3409″ img_size=”large”][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]

Su questo sito Web utilizziamo strumenti proprietari o di terze parti che memorizzano piccoli file (cookie) sul tuo dispositivo. I cookie vengono normalmente utilizzati per consentire il corretto funzionamento dei siti web (cookie tecnici), per generare report sull’utilizzo della navigazione (cookie statistici) e per pubblicizzare servizi / prodotti (cookie di profilazione). Possiamo utilizzare direttamente i cookie tecnici, ma hai il diritto di scegliere se abilitare o meno i cookie statistici e di profilazione (noi non usiamo cookie di profilazione). Vedi privacy policy.
Abilitando questi cookie, ci aiuti a offrirti un’esperienza migliore
.